1001-5256
2014 Issue 9
Improving understanding of liver immune function and enhancing research on cell therapy for liver diseases
JIA Zhansheng;,LIAN Jianqi;
JIA Zhansheng;,LIAN Jianqi;
..............page:839-841
World Gastroenterology Organisation global guidelines:nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
WANG Yuming;,XU Zong;,ZHU Peng;
WANG Yuming;,XU Zong;,ZHU Peng;
..............page:842-845
Current status of research on liver innate immunity
WEI Xin;,YE Chuantao;,ZHANG Ying;
WEI Xin;,YE Chuantao;,ZHANG Ying;
..............page:846-850
ci gong zhen dan xing cheng xiang zai dai chang qi he shi dai chang qi gan zang ji bing zhong de zuo yong
wang zhong feng ;, zuo su ;
wang zhong feng ;, zuo su ;
..............page:850-850
Persistent hepatitis virus infection and immune homeostasis
JIA Zhansheng;,LIAN Jianqi;,ZHOU Yun;
JIA Zhansheng;,LIAN Jianqi;,ZHOU Yun;
..............page:851-854
Immunoregulatory effect of multipotent stem cells in liver injury and repair
CUI Lina;,HAN Ying;
CUI Lina;,HAN Ying;
..............page:855-859
Research advances in cellular immunotherapy for primary hepatocellular carcinoma
JIA Zhansheng;,ZHANG Mingjie;,ZHANG Ye;
JIA Zhansheng;,ZHANG Mingjie;,ZHANG Ye;
..............page:860-864
gan ying hua huan zhe gan ran xiang guan de 1 xing gan shen zong he zheng zi ran shi shen gong neng jie ju ji sheng cun lv
gao yang ;, li wan yu ;
gao yang ;, li wan yu ;
..............page:864-864
Role of cancer-associated fibroblasts in growth and metastasis of hepatocellular carcinoma
MA Dening;,TANG Zhaoyou;,ZHU Xiaodong;
MA Dening;,TANG Zhaoyou;,ZHU Xiaodong;
..............page:865-868
Efficacy and safety of UCB-derived or autologous CIK cells combined with interferon therapy in patients with chro-nic hepatitis B
chen cong xin ;, dong jing ;, liu bo ;, song hai yan ;, zhang jun fei ;
chen cong xin ;, dong jing ;, liu bo ;, song hai yan ;, zhang jun fei ;
..............page:869-872
In vitro proliferation capacity and killing efficacy of CIK cells from umbilical cord blood versus patients with chronic hepatitis B
li jia jia ;, liu bo ;, liu li wei ;, zhu li xin ;
li jia jia ;, liu bo ;, liu li wei ;, zhu li xin ;
..............page:873-876
yi xiang guan yu yao wu he zhong yao yin qi de gan sun shang de dan zhong xin bing li xi lie yan jiu
li wan yu ;, liu yong fang ;
li wan yu ;, liu yong fang ;
..............page:876-876
Toll-like receptor 2 drives Th17 cell activation in inflammatory response to hepatitis B virus infection
dong jie ;, huang chang xing ;, lian jian qi ;, yang xiao fei ;, zhang ye ;, zhao rong rong ;
dong jie ;, huang chang xing ;, lian jian qi ;, yang xiao fei ;, zhang ye ;, zhao rong rong ;
..............page:877-881
..............page:881-881
Changes in peripheral blood T cell subsets and TGFβand their clinical significance among HBV infection patients with different viral loads
chen xi lian ;, duan zheng jun ;, li cai dong ;, tian peng fei ;, wu bin ;
chen xi lian ;, duan zheng jun ;, li cai dong ;, tian peng fei ;, wu bin ;
..............page:882-886
Effects of splenectomy on peripheral blood Th17 cells and immune function in patients with portal hypertension
CHEN Yijie;,LIU Chaohui;,ZHANG Chenghua;
CHEN Yijie;,LIU Chaohui;,ZHANG Chenghua;
..............page:887-890
Inhibitory effect of iAPA-DC/CTL on HepG2 xenograft in nude mice
ding you ming ;, fu hai feng ;, wang bin ;, xu jun hui ;, xu yan zhe ;, zhou wen bo ;
ding you ming ;, fu hai feng ;, wang bin ;, xu jun hui ;, xu yan zhe ;, zhou wen bo ;
..............page:891-894
Analysis of predictors of liver injury stage in chronic HBV infection patients with ALT levels lower than 2 ×ULN
wang zuo hong ;, yang rui ;, zhang guang wen ;, zhang ya ping ;, zhu bin ;
wang zuo hong ;, yang rui ;, zhang guang wen ;, zhang ya ping ;, zhu bin ;
..............page:895-898
Changing process and development trend of deaths (mortality)in patients with viral hepatitis in China
HE Shuping;,LIANG Qin;,ZHAO Zhen;
HE Shuping;,LIANG Qin;,ZHAO Zhen;
..............page:899-902
Risk factors for non-alcoholic fatty liver disease:a multivariate analysis
chen wei chang ;, feng zuo ;, pang xue qin ;, tian wen zuo ;
chen wei chang ;, feng zuo ;, pang xue qin ;, tian wen zuo ;
..............page:903-905
Establishment and management of nonalcoholic fatty liver disease biobank
chen li zhen ;, geng ning ;, jiang man ;, liu zuo gang ;, niu tong hong ;, wang jian ;, xin yong ning ;, xuan shi ying ;, zhang hai ying ;
chen li zhen ;, geng ning ;, jiang man ;, liu zuo gang ;, niu tong hong ;, wang jian ;, xin yong ning ;, xuan shi ying ;, zhang hai ying ;
..............page:906-909
..............page:909-909
Experience in perioperative management in difficult laparoscopic cholecystectomy
chen zhan hui ;, li dong wei ;, li jun jiu ;, tang shi long ;, zeng yong feng ;, zhang xiao bing ;
chen zhan hui ;, li dong wei ;, li jun jiu ;, tang shi long ;, zeng yong feng ;, zhang xiao bing ;
..............page:910-912
Clinical effects of comprehensive treatment and liver transplantation for hepatocellular carcinoma exceeding Milan criteria:a comparative study
CAI Qiucheng;,JIANG Yi;,LIU Jianyong;
CAI Qiucheng;,JIANG Yi;,LIU Jianyong;
..............page:913-916
Efficacy of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma before hepatectomy:a meta-analysis
gao sheng ;, liu jian yong ;, wu fei xiang ;, xiang bang de ;, yuan wei ping ;, zhang zhi ming ;, zhao yin nong ;
gao sheng ;, liu jian yong ;, wu fei xiang ;, xiang bang de ;, yuan wei ping ;, zhang zhi ming ;, zhao yin nong ;
..............page:917-920
Correlation of GGT with AFP and diagnostic value of GGT for hepatocellular carcinoma
FANG Long;,GAO Chun;,YAO Shukun;
FANG Long;,GAO Chun;,YAO Shukun;
..............page:921-925
..............page:925-925
Relationship between classification of Doppler ultrasound blood flow signals and angiogenesis in primary hepatocellu-lar carcinoma
LIU Ying;,MA Yanyan;,ZHANG Jingzhuo;
LIU Ying;,MA Yanyan;,ZHANG Jingzhuo;
..............page:926-928
Dynamic changes in B7-H1 expression on peripheral blood mononuclear cells in chronic hepatitis B patients treated with entecavir
chen tian yan ;, zuo shu mei ;, wu lie xiu ;, ye feng ;, zhang shu lin ;, zhang zuo ;, zhao ying ren ;, zheng shu qin ;
chen tian yan ;, zuo shu mei ;, wu lie xiu ;, ye feng ;, zhang shu lin ;, zhang zuo ;, zhao ying ren ;, zheng shu qin ;
..............page:929-931
Abernethy malformation misdiagnosed as liver cirrhosis:a report of one case
gou chun yan ;, li jing zuo ;, li li ;, li xiu hui ;
gou chun yan ;, li jing zuo ;, li li ;, li xiu hui ;
..............page:932-934
..............page:934-934
Research progress in TIM-3 and HBV infection
dong jie ;, huang chang xing ;, lian jian qi ;, shen huan jun ;, yang xiao fei ;, zhang ye ;, zhao rong rong ;, zhao yan yan ;
dong jie ;, huang chang xing ;, lian jian qi ;, shen huan jun ;, yang xiao fei ;, zhang ye ;, zhao rong rong ;, zhao yan yan ;
..............page:935-938
..............page:938-938
..............page:939-943
lin chuang yao li xue yu zhi liao xue 2015 nian zheng ding qi shi
zhong guo lin chuang yao li xue yu zhi liao xue za zhi she ;
zhong guo lin chuang yao li xue yu zhi liao xue za zhi she ;
..............page:943-943
Current status and progress in research on helicobacter infection and chronic liver diseases
CHI Zhaochun;
CHI Zhaochun;
..............page:944-947
Research advances in animal models of nonalcoholic fatty liver disease
huang hai yan ;, jiang man ;, jiang xiang jun ;, jin wen wen ;, xin yong ning ;, xuan shi ying ;
huang hai yan ;, jiang man ;, jiang xiang jun ;, jin wen wen ;, xin yong ning ;, xuan shi ying ;
..............page:948-953
Role of PI3 K/Akt/mTOR signaling pathway in hepatocellular carcinoma
CHEN Xiaorong;,YU Yuan;
CHEN Xiaorong;,YU Yuan;
..............page:954-957
..............page:955-955
en ti ka wei bu neng xiao chu man xing yi xing gan yan huan zhe gan ai de fa sheng feng xian zai bai zhong ren qun feng xian ping fen zhong de you xian zuo yong
sun li ;, wen xiao yu ;
sun li ;, wen xiao yu ;
..............page:957-957
Application of proteomics in study of hepatocellular carcinoma
FEI Xinying;,SONG Qing;,WANG Jiangang;
FEI Xinying;,SONG Qing;,WANG Jiangang;
..............page:958-960
Progress in evaluation and treatment of hepatic iron overload
DING Rui;,JIA Jidong;
DING Rui;,JIA Jidong;
..............page:961-964
man xing yi xing gan yan huan zhe ting yong he zuo ji he zuo suan lei yao wu shi xue qing hbv dna can yu liang ke yu ce ting yao hou de fu fa
lu wang ;, wen xiao yu ;
lu wang ;, wen xiao yu ;
..............page:964-964
Research advances in circulating miRNAs for diagnosis of hepatobiliary diseases
LIU Haiying;,PENG Xiaofang;
LIU Haiying;,PENG Xiaofang;
..............page:965-968